Agreement with Lamellar good/bad?8 May 2019 15:39
On paper it looks good offcourse however can't help but feel they are in the know of no hope of utilizing Iclaprim for all its full potential and this is almost a last resort to keep it still relevant? Or are they hopeful of being bought out and let the other company continue a path forward with the FDA? Uncertain times and having already lost a few k in this company being a complete novice and buying into the hype I regrettably don't see light at the end of the tunnel here. Sincerely hope I am proven wrong?
What's the more experienced opinion on the subject question amd the future for Motif?